These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7999969)
61. Hormonal control of 17 beta-estradiol biosynthesis in proestrous rat follicles: estradiol production by isolated theca versus granulosa. Fortune JE; Armstrong DT Endocrinology; 1978 Jan; 102(1):227-35. PubMed ID: 570480 [No Abstract] [Full Text] [Related]
62. Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Schenker JG; Weinstein D; Okon E Cancer; 1979 Nov; 44(5):1809-12. PubMed ID: 498050 [TBL] [Abstract][Full Text] [Related]
64. The hormonal activity of the postmenopausal ovary. Vermeulen A J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438 [TBL] [Abstract][Full Text] [Related]
65. Plasma androstenedione levels in women with breast cancer. Wang DY; Bulbrook RD; Hayward JL Eur J Cancer (1965); 1977 Feb; 13(2):187-92. PubMed ID: 140053 [No Abstract] [Full Text] [Related]
66. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women. Maroulis GB; Abraham GE Obstet Gynecol; 1976 Aug; 48(2):150-4. PubMed ID: 133306 [TBL] [Abstract][Full Text] [Related]
67. Pelvic radiotherapy, sex hormones, and breast cancer. Inskip PD Cancer Causes Control; 1994 Sep; 5(5):471-8. PubMed ID: 7999969 [TBL] [Abstract][Full Text] [Related]
68. Sex hormones and cardiovascular risk. La Vecchia C Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926 [TBL] [Abstract][Full Text] [Related]
70. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. Labrie F J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731 [TBL] [Abstract][Full Text] [Related]
71. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
72. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. Colditz GA J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169 [TBL] [Abstract][Full Text] [Related]
73. Breast cancer in men. Thomas DB Epidemiol Rev; 1993; 15(1):220-31. PubMed ID: 8405206 [TBL] [Abstract][Full Text] [Related]
74. A review of the epidemiology of human breast cancer. Kelsey JL Epidemiol Rev; 1979; 1():74-109. PubMed ID: 398270 [TBL] [Abstract][Full Text] [Related]
75. Epidemiologic analysis of breast and gynecologic cancers. Hulka BS Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587 [TBL] [Abstract][Full Text] [Related]
76. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Labrie F; Labrie C Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249 [TBL] [Abstract][Full Text] [Related]
77. The prevention of breast cancer through reduced ovarian steroid exposure. Spicer DV; Pike MC Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631 [TBL] [Abstract][Full Text] [Related]
78. Does HRT modify risk of gynecological cancers? Schneider HP; Birkhauser M Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588 [TBL] [Abstract][Full Text] [Related]
79. [Cancer risk under hormone therapy]. Lauritzen C Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334 [TBL] [Abstract][Full Text] [Related]